Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
- PMID: 23260189
- DOI: 10.1016/S1474-4422(12)70296-X
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
Abstract
Human African trypanosomiasis, or sleeping sickness, is caused by infection with parasites of the genus Trypanosoma, transmitted by the tsetse fly. The disease has two forms, Trypanosoma brucei (T b) rhodesiense and T b gambiense; and is almost always fatal if untreated. Despite a recent reduction in the number of reported cases, patients with African trypanosomiasis continue to present major challenges to clinicians. Because treatment for CNS-stage disease can be very toxic, diagnostic staging to distinguish early-stage from late-stage disease when the CNS in invaded is crucial but remains problematic. Melarsoprol is the only available treatment for late-stage T b rhodesiense infection, but can be lethal to 5% of patients owing to post-treatment reactive encephalopathy. Eflornithine combined with nifurtimox is the first-line treatment for late-stage T b gambiense. New drugs are in the pipeline for treatment of CNS human African trypanosomiasis, giving rise to cautious optimism.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Priorities for the elimination of sleeping sickness.Adv Parasitol. 2012;79:299-337. doi: 10.1016/B978-0-12-398457-9.00004-4. Adv Parasitol. 2012. PMID: 22726645 Review.
-
Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.Front Immunol. 2019 Jan 25;10:39. doi: 10.3389/fimmu.2019.00039. eCollection 2019. Front Immunol. 2019. PMID: 30740102 Free PMC article. Review.
-
Update on human African trypanosomiasis (sleeping sickness).J Neurol. 2019 Sep;266(9):2334-2337. doi: 10.1007/s00415-019-09425-7. Epub 2019 Jun 17. J Neurol. 2019. PMID: 31209574 Review.
-
The continuing problem of human African trypanosomiasis (sleeping sickness).Ann Neurol. 2008 Aug;64(2):116-26. doi: 10.1002/ana.21429. Ann Neurol. 2008. PMID: 18756506 Review.
-
[Human African trypanosomiasis].C R Seances Soc Biol Fil. 1996;190(4):395-408. C R Seances Soc Biol Fil. 1996. PMID: 8952890 Review. French.
Cited by
-
From Ocean to Medicine: Pharmaceutical Applications of Metabolites from Marine Bacteria.Antibiotics (Basel). 2020 Jul 28;9(8):455. doi: 10.3390/antibiotics9080455. Antibiotics (Basel). 2020. PMID: 32731464 Free PMC article. Review.
-
Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse.PLoS Negl Trop Dis. 2022 Dec 7;16(12):e0010962. doi: 10.1371/journal.pntd.0010962. eCollection 2022 Dec. PLoS Negl Trop Dis. 2022. PMID: 36477669 Free PMC article.
-
Pyrimidine Salvage Enzymes Are Essential for De Novo Biosynthesis of Deoxypyrimidine Nucleotides in Trypanosoma brucei.PLoS Pathog. 2016 Nov 7;12(11):e1006010. doi: 10.1371/journal.ppat.1006010. eCollection 2016 Nov. PLoS Pathog. 2016. PMID: 27820863 Free PMC article.
-
Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1.Antiviral Res. 2020 Jan;173:104649. doi: 10.1016/j.antiviral.2019.104649. Epub 2019 Nov 8. Antiviral Res. 2020. PMID: 31711927 Free PMC article.
-
Integration of Human African Trypanosomiasis Control Activities into Primary Healthcare Services: A Scoping Review.Am J Trop Med Hyg. 2019 Nov;101(5):1114-1125. doi: 10.4269/ajtmh.19-0232. Am J Trop Med Hyg. 2019. PMID: 31482788 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources